Objectives: To investigate the safety, effectiveness, and risk-benefit balance of intravenous abatacept (ABA) in non-elderly ( Methods: This sub-analysis of an all-cases postmarketing surveillance in Japan assessed safety in all enrolled patients and effectiveness in those with Disease Activity Score 28 based on C-reactive protein (DAS28-CRP) measurements at ≥2 time points including baseline. Risk-benefit was evaluated based on infections and DAS28-CRP improvement >1.2. Results: The NEG and EG of the safety analysis set comprised 2,170 and 1,712 patients, respectively; corresponding 6-month ABA retention rates were 80.2% and 77.1%. The NEG had fewer adverse drug reactions (14.5% vs. 17.2%, p = .021) and infections (4.8% vs. 7.2%, p = .002) ...
Background: There are limited data regarding efficacy of abatacept treatment for rheumatoid arthriti...
Objective To assess safety, immunogenicity and effi cacy in rheumatoid arthritis (RA) patients switc...
Objective: To review and update the pharmacology, pharmacokinetics, safety, precautions, efficacy, a...
Objective: To perform a postmarketing surveillance study evaluating the safety and effectiveness of ...
Background and Objectives: Treatment for elderly (aged ≥75 years) patients with rheumatoid arthritis...
The aim of this study was to assess abatacept in rheumatoid arthritis (RA) patient. Patients (20 men...
International audienceOBJECTIVE:To study the effect of age on the risk-benefit balance of abatacept ...
Objectives: To evaluate the real-world safety and effectiveness of etanercept (ETN) in Japanese pati...
Background: To investigate efficacy and safety of intravenous abatacept in Japanese patients with ac...
Objectives: To assess the effectiveness, safety, and drug survival of subcutaneous (SC) abatacept (A...
<p><strong>Objective</strong>: to compare the efficacy and safety of abatacept (ABC) in patients wit...
OBJECTIVE: To assess 5-year safety, tolerability, and efficacy of subcutaneous (SC) abatacept (ABA) ...
Favorable efficacy and safety profiles have been demonstrated for abatacept in patients with rheumat...
Favorable efficacy and safety profiles have been demonstrated for abatacept in patients with rheumat...
Objectives. To examine the long-term safety of intravenous (IV) abatacept treatment in Japanese pati...
Background: There are limited data regarding efficacy of abatacept treatment for rheumatoid arthriti...
Objective To assess safety, immunogenicity and effi cacy in rheumatoid arthritis (RA) patients switc...
Objective: To review and update the pharmacology, pharmacokinetics, safety, precautions, efficacy, a...
Objective: To perform a postmarketing surveillance study evaluating the safety and effectiveness of ...
Background and Objectives: Treatment for elderly (aged ≥75 years) patients with rheumatoid arthritis...
The aim of this study was to assess abatacept in rheumatoid arthritis (RA) patient. Patients (20 men...
International audienceOBJECTIVE:To study the effect of age on the risk-benefit balance of abatacept ...
Objectives: To evaluate the real-world safety and effectiveness of etanercept (ETN) in Japanese pati...
Background: To investigate efficacy and safety of intravenous abatacept in Japanese patients with ac...
Objectives: To assess the effectiveness, safety, and drug survival of subcutaneous (SC) abatacept (A...
<p><strong>Objective</strong>: to compare the efficacy and safety of abatacept (ABC) in patients wit...
OBJECTIVE: To assess 5-year safety, tolerability, and efficacy of subcutaneous (SC) abatacept (ABA) ...
Favorable efficacy and safety profiles have been demonstrated for abatacept in patients with rheumat...
Favorable efficacy and safety profiles have been demonstrated for abatacept in patients with rheumat...
Objectives. To examine the long-term safety of intravenous (IV) abatacept treatment in Japanese pati...
Background: There are limited data regarding efficacy of abatacept treatment for rheumatoid arthriti...
Objective To assess safety, immunogenicity and effi cacy in rheumatoid arthritis (RA) patients switc...
Objective: To review and update the pharmacology, pharmacokinetics, safety, precautions, efficacy, a...